Citadel Advisors LLC 13D and 13G filings for Janux Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 4:17 pm Sale |
2024-09-30 | 13G | Janux Therapeutics, Inc. JANX |
Citadel Advisors LLC | 1,021,403 2.000% |
-2,104,494 (-67.32%) |
Filing |
| 2024-02-14 4:58 pm Purchase |
2023-12-31 | 13G | Janux Therapeutics, Inc. JANX |
Citadel Advisors LLC | 3,125,897 6.800% |
999,762 (+47.02%) |
Filing |
| 2023-07-10 4:01 pm Purchase |
2023-06-29 | 13G | Janux Therapeutics, Inc. JANX |
Citadel Advisors LLC | 2,126,135 5.100% |
2,126,135 (New Position) |
Filing |